After setting record closes last week, the markets retreated with the Dow losing 54 points to 19,097 on profit taking. Nasdaq dropped 30 points 5,368.
On the upside
Shares of Heat Biologics (Nasdaq: HTBX) continued to surge ahead of its Phase 1b study data presentation next week at the International Society for the Study of Lung Cancer Annual Meeting for its lung cancer treatment HS-110 in combination with Bristol-Myers Squibb's anti-PD-1 checkpoint inhibitor nivolumab.
The Herzfeld Caribbean Basin Fund (Nasdaq: CUBA) climbed after the death of Cuban dictator Fidel Castro.
Under Armour (NYSE: UA) will change the ticker symbols for its Class A common stock from UA to UAA and Class C common stock from UA.C to UA beginning December 7, 2016.
On the downside
Alder BioPharmaceuticals (Nasdaq: ALDR) initiated a PROMISE 2 clinical trial of its migraine prevention drug eptinezumab but the stock price fell.
Diana Containerships (Nasdaq: DCIX) hosted a webcast and teleconference to discuss its third quarter results this morning.
Profit taking weighed down shares of Ophthotech (Nasdaq: OPTH).
In the broad market, declining issues outpaced advancers by a margin of nearly 2 to 1 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 fell 11 points to 2,201. Bitcoin rose $2 to $730.
